TwinBeech Capital’s Twist Bioscience TWST Stock Holding History

TwinBeech Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$988K	Buy	+9,600	New	+$625K	0.18%	155
2024 Q4	–	Sell	-28,966	Closed	-$1.31M	–	932
2024 Q3	$1.31M	Buy	+28,966	New	+$1.38M	0.03%	471
2024 Q2	–	Sell	-40,750	Closed	-$1.4M	–	791
2024 Q1	$1.4M	Buy	+40,750	New	+$1.47M	0.03%	386
2023 Q4	–	Sell	-33,439	Closed	-$677K	–	910
2023 Q3	$677K	Buy	+33,439	New	+$735K	0.01%	525
2023 Q2	–	Sell	-135,485	Closed	-$2.04M	–	868
2023 Q1	$2.04M	Buy	+135,485	New	+$2.99M	0.04%	375
2021 Q1	–	Sell	-3,720	Closed	-$526K	–	679
2020 Q4	$526K	Buy	+3,720	New	+$413K	0.09%	277

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

TwinBeech Capital's TWST Position: Q2 2026 in Review

TwinBeech Capital opened a new position in Twist Bioscience (TWST) in Q2 2026: 9,600 shares worth $988K. The stake represents 0.18% of the portfolio and ranks #155 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in TWST as recently as Q3 2024.

TwinBeech Capital first reported a position in TWST in Q4 2020 and has held it in 6 quarters since. The position peaked at $2.04M in Q1 2023. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

TwinBeech Capital held 9,600 shares of Twist Bioscience worth $988K as of Q2 2026.
Twist Bioscience was a new TwinBeech Capital position in Q2 2026.
Twist Bioscience made up 0.18% of TwinBeech Capital's portfolio in Q2 2026, its #155 holding.
TwinBeech Capital first reported a position in Twist Bioscience in Q4 2020 and has held it in 6 quarters since.
TwinBeech Capital's Twist Bioscience position peaked at $2.04M in Q1 2023.
337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.